ATE453627T1 - Herstellung von verbindungen zur bestimmung der hypoxie - Google Patents

Herstellung von verbindungen zur bestimmung der hypoxie

Info

Publication number
ATE453627T1
ATE453627T1 AT00960168T AT00960168T ATE453627T1 AT E453627 T1 ATE453627 T1 AT E453627T1 AT 00960168 T AT00960168 T AT 00960168T AT 00960168 T AT00960168 T AT 00960168T AT E453627 T1 ATE453627 T1 AT E453627T1
Authority
AT
Austria
Prior art keywords
compounds
methods
preparation
preparing
disclosed
Prior art date
Application number
AT00960168T
Other languages
English (en)
Inventor
William Dolbier
An-Rong Li
Cameron Koch
Alexander Kachur
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of ATE453627T1 publication Critical patent/ATE453627T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00960168T 1999-07-21 2000-07-20 Herstellung von verbindungen zur bestimmung der hypoxie ATE453627T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14474799P 1999-07-21 1999-07-21
PCT/US2000/040437 WO2001007414A1 (en) 1999-07-21 2000-07-20 Preparation of compounds useful for the detection of hypoxia

Publications (1)

Publication Number Publication Date
ATE453627T1 true ATE453627T1 (de) 2010-01-15

Family

ID=22509947

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00960168T ATE453627T1 (de) 1999-07-21 2000-07-20 Herstellung von verbindungen zur bestimmung der hypoxie

Country Status (9)

Country Link
US (1) US7432295B2 (de)
EP (2) EP1202973B1 (de)
JP (1) JP5085824B2 (de)
AT (1) ATE453627T1 (de)
AU (1) AU780133B2 (de)
CA (1) CA2379974C (de)
DE (1) DE60043616D1 (de)
ES (1) ES2340912T3 (de)
WO (1) WO2001007414A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04005689A (es) 2001-12-12 2004-12-06 Single Buoy Moorings Sistema de descarga de lng por veleo.
CN101437575B (zh) 2006-02-01 2015-04-08 皇家飞利浦电子股份有限公司 改良的放射治疗规划方案
DE102006015467A1 (de) 2006-03-31 2007-10-04 Bayer Cropscience Ag Substituierte Enaminocarbonylverbindungen
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
MX2009007395A (es) * 2007-01-09 2009-07-17 Bayer Schering Pharma Ag Marcacion radioactiva por fluoracion de aziridinas.
EP2039678A1 (de) 2007-09-18 2009-03-25 Bayer CropScience AG Verfahren zum Herstellen von 4-Aminobut-2-enoliden
EP2107058A1 (de) 2008-03-31 2009-10-07 Bayer CropScience AG Substituierte Enaminothiocarbonylverbindungen
WO2010068238A1 (en) * 2008-12-10 2010-06-17 Albert Einstein College Of Medicine Of Yeshiva University Hypoxia targeted compounds for cancer diagnosis and therapy
WO2010135180A1 (en) * 2009-05-19 2010-11-25 The Trustees Of The University Of Pennsylvania Catalysis of fluorine addition to double bonds
EP2264008A1 (de) 2009-06-18 2010-12-22 Bayer CropScience AG Substituierte Enaminocarbonylverbindungen
KR20170058360A (ko) * 2014-09-25 2017-05-26 니혼 메디피직스 가부시키가이샤 신장 이미징제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505349A (en) * 1966-04-18 1970-04-07 Hoffmann La Roche 2-nitro-imidazolyl-1-acetamides
EP0669913B1 (de) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Nachweis von hypoxia
US6252087B1 (en) 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US5721265A (en) * 1994-08-05 1998-02-24 Sri International Fluorinated 2-nitroimidazole analogs for detecting hypoxic tumor cells
US7230115B1 (en) 1999-07-21 2007-06-12 The Trustees Of The University Of Pennsylvania Preparation of compounds useful for the detection of hypoxia
GB9917725D0 (en) 1999-07-28 1999-09-29 Medical Res Council Peptides
EP3894044B1 (de) 2018-11-29 2025-09-24 Fluitec N.V. Filtergehäuse, reinigungskufen und verwendungsverfahren dafür

Also Published As

Publication number Publication date
EP1202973A4 (de) 2004-08-18
DE60043616D1 (de) 2010-02-11
AU7136800A (en) 2001-02-13
EP1202973A1 (de) 2002-05-08
CA2379974C (en) 2011-10-25
WO2001007414A1 (en) 2001-02-01
US7432295B2 (en) 2008-10-07
CA2379974A1 (en) 2001-02-01
JP5085824B2 (ja) 2012-11-28
US20060159618A1 (en) 2006-07-20
JP2004501055A (ja) 2004-01-15
ES2340912T3 (es) 2010-06-11
EP1202973B1 (de) 2009-12-30
AU780133C (en) 2001-02-13
AU780133B2 (en) 2005-03-03
EP2098514A1 (de) 2009-09-09

Similar Documents

Publication Publication Date Title
CY1109151T1 (el) Αντισωματα dr4 και χρησεις αυτων
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
IL159527A0 (en) Human dr4 antibodies and uses thereof
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
EP0911390A3 (de) Protein-Kinases als Werkzeuge zur Diagnose und Behandlung von Alzheimer's Krankheit
IE902347L (en) Indole derivatives
DE60043616D1 (de) Herstellung von verbindungen zur bestimmung der hypoxie
CA2299504A1 (en) Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma
ATE452655T1 (de) Verwendung von l-polynukleotiden zur diagnostischen bilderzeugung
TR199903154T2 (xx) Meme kanserinin tedavisi ve te�hisi i�in bile�imler ve y�ntemler
DE69033745D1 (de) Oberflächenaktive zusammensetzungen und verfahren
DK1021534T3 (da) Hepatitis C-receptorprotein CD81
ATE258933T1 (de) Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie
EP1532162A4 (de) Humanisierter anti-tag-72 cc49 zur diagnose und therapie humaner tumore
ATE77957T1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
ATE480243T1 (de) Zusammensetzung zur verwendung bei diagnose der akuten verletzungen des zentralen nervensystems
FI965094L (fi) 2,4,6-trijodi-5-substituoituja aminoisoftalaattiestereitä, jotka ovat hyödyllisiä varjoaineina lääketieteellisessä diagnostisessa kuvauksessa
ATE353019T1 (de) Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
DE69901519D1 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE3863136D1 (de) Derivate des 2,2-bis-(3-aminophenyl)-hexafluorpropans und verfahren zur herstellung des 2,2-bis-(3,4-diaminophenyl)-hexafluorpropans.
DE60000274D1 (de) Verfahren zur Herstelung von Pirlindolehydrochlorid
DE69903610D1 (de) Verfahren zur Herstellung von 5,5'-bi-1H-Tetrazol-Salz
EP1233075A3 (de) BDNF Polymorphismus und Vereinigung mit doppelpoliger Geistesgestörtheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties